Fezolinetant

CHEMBL3608680 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
358.4 g/mol
LogP
1.6
Phase
4

A non-hormonal medication that works by blocking neurokinin 3 receptors in the brain to reduce the frequency and severity of hot flashes in postmenopausal women. It provides relief without the use of estrogen, making it an option for those who cannot or prefer not to use hormone therapy.

Khối lượng phân tử

358,4000 g/mol

LogP

1,60

TPSA

105,00 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1

InChI

InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1

Molecular Formula

C16H15FN6OS

HBD / HBA

- / 7

Liên kết có thể quay

2

Nguyên tử nặng

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A non-hormonal medication that works by blocking neurokinin 3 receptors in the brain to reduce the frequency and severity of hot flashes in postmenopausal women. It provides relief without the use of estrogen, making it an option for those who cannot or prefer not to use hormone therapy.

Yes, Fezolinetant is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3608680. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 117604931. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.